SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...

The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

(NewsNation) — An estimated 15.5 million U.S. adults have used injectable diabetes medicines like Ozempic and Wegovy to lose weight, according to a Gallup poll released Tuesday. The nationwide survey ...

WASHINGTON (AP) — The Food and Drug Administration has approved a new injectable diabetes drug from Eli Lilly and Co. for adults with the most common form of the disease. The agency on Thursday ...

The new therapy comes from Duke University (the laboratory of Dr. Ashutosh Chilkoti) and the reason that the single injection lasts for so long is due to a controlled-release mechanism, whereby the ...

Ozempic, Wegovy and other GLP-1 medications have gained widespread popularity for weight loss and diabetes control in recent years — but the spike in demand has made it difficult for some people to ...

WASHINGTON (AP) — The Food and Drug Administration said Tuesday it approved a new injectable drug from GlaxoSmithKline plc for adults with Type 2 diabetes. The agency cleared the company’s drug, ...

Once-weekly semaglutide 1 mg was tied to a reduction in total daily insulin dose among adults with type 1 diabetes, ...

West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 14 Best Dividend Growth Stocks to Buy and Hold in 2026.

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (NewsNation) — An estimated 15.5 million U.S ...